Well I've been wrong on a couple of things.
I was wrong to suggest that the BLA resubmission had a 50% chance of success
But I was right that they would finally have to do another proper clinical trial for aGVHD, and that resubmitting the BLA wouldn't be a satisfactory milestone to unlock the additional Oaktree Loan.
I was right that Oaktree wouldn't extend the loan agreement.
I was right that Novartis was going to walk away from the collaboration for Covid ARDS research.
I was right that apart from the claimed success in the unsatisfactory single arm open label trial for aGVHD, every Mesoblast trial has failed to achieve the primary endpoint.
I was right that Mesoblast has effectively run out of funds, and will have difficulty finding another sucker.
- Forums
- ASX - By Stock
- banter and General Discussion
Well I've been wrong on a couple of things. I was wrong to...
-
- There are more pages in this discussion • 2,783 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B |
Open | High | Low | Value | Volume |
94.0¢ | 96.8¢ | 93.5¢ | $4.207M | 4.417M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 42268 | 94.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.0¢ | 48002 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 41000 | 0.940 |
4 | 39720 | 0.935 |
1 | 20000 | 0.930 |
6 | 60000 | 0.925 |
2 | 431086 | 0.920 |
Price($) | Vol. | No. |
---|---|---|
0.950 | 30347 | 2 |
0.955 | 20000 | 1 |
0.960 | 47000 | 2 |
0.965 | 35223 | 3 |
0.970 | 259286 | 4 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |